Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 USD | +400.00% | 0.00% | -83.33% |
Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Financials (USD)
Sales 2021 | 17.5M | Sales 2022 | 49.72M | Capitalization | 111M |
---|---|---|---|---|---|
Net income 2021 | -64M | Net income 2022 | -51M | EV / Sales 2021 | 5.55 x |
Net Debt 2021 | 7.2M | Net Debt 2022 | 12.95M | EV / Sales 2022 | 2.49 x |
P/E ratio 2021 |
-1.12
x | P/E ratio 2022 |
-1.95
x | Employees | 125 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.32% |
Latest transcript on RVL Pharmaceuticals plc
1 day | +400.00% | ||
1 month | +400.00% | ||
3 months | +400.00% | ||
6 months | -97.30% | ||
Current year | -83.33% |
Managers | Title | Age | Since |
---|---|---|---|
Sergio Alegre
CMP | Compliance Officer | - | 16-07-31 |
James Schaub
COO | Chief Operating Officer | 42 | 15-12-31 |
Michael Depetris
AUD | Comptroller/Controller/Auditor | - | 22-04-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Cowan
BRD | Director/Board Member | 70 | 18-12-31 |
Alisa Lask
BRD | Director/Board Member | 53 | 22-08-09 |
Michael DeBiasi
BRD | Director/Board Member | 48 | 19-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.0005 | +400.00% | 139,840 |
Delayed Quote OTC Markets, May 03, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-83.33% | 55.7K | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- RVLPQ Stock